Special Issue "Clinical Analysis of Treatment of Uveitis Complicated with Cataract"
Deadline for manuscript submissions: closed (15 October 2023) | Viewed by 1123
Interests: uveitis; medical retina; pediatric retina; intraocular tumors
Uveitis, both non-infectious and often infectious, is a chronic and progressive disease that represents a permanent threat to visual function. Treatment of uveitis with the aim of minimizing inflammation and avoiding complications represents a huge challenge for ophthalmologists.
One of the most common complications of chronic uveitis is a complicated cataract that occurs as a result of inflammation and local and systemic corticosteroid therapy. Although our therapy is aimed at controlling inflammation using non-steroidal immunosuppressive therapy, especially biological drugs, and minimizing systemic and local exposure to corticosteroids, cataracts in uveitis often cannot be avoided. We should think about minimizing the risk of complicated cataracts before their appearance, especially in small children and young patients. However, when a cataract becomes a problem for visual function, knowledge of the etiology, the clinical course of uveitis, careful evaluation of other complications, and condition of the anterior and posterior eye segment help to choose the optimal time for surgery with careful preoperative management of the patient. The strict control of inflammation before the surgery, adequate surgical technique, and intensive postoperative anti-inflammatory therapy with early recognition and prompt treatment of complications contribute to a better outcome of the surgery.
The goal of this Special Issue is to collect scientific and professional articles that are focused on minimization of the risk of developing complicated cataracts and surgical management of cataracts with adequate inflammation control in patients with uveitis.
Dr. Nenad Vukojević
Dr. Nataša Vidovič-Valentinčič
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- intraocular inflammation
- immunosuppressive drugs
- visual function